NFSG
SGMT icon

Newbridge Financial Services Group’s Sagimet Biosciences SGMT Stock Holding History

Newbridge Financial Services Group’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.84K Hold
1,500
– – ﹤0.01% 835
2025
Q4 		$8.88K Hold
1,500
– – ﹤0.01% 799
2025
Q3 		$10.3K Hold
1,500
– – ﹤0.01% 896
2025
Q2 		$11.4K Hold
1,500
– – ﹤0.01% 851
2025
Q1 		$4.89K Hold
1,500
– – ﹤0.01% 802
2024
Q4 		$6.75K Buy
+1,500
New +$7.6K ﹤0.01% 812
2024
Q3 		– Sell
-1,500
Closed -$5.13K – 1032
2024
Q2 		$5.13K Hold
1,500
– – ﹤0.01% 837
2024
Q1 		$8.13K Hold
1,500
– – ﹤0.01% 812
2023
Q4 		$8.13K Buy
+1,500
New +$7.08K ﹤0.01% 783

Other funds holding SGMT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Newbridge Financial Services Group's SGMT Position: Q1 2026 in Review

Newbridge Financial Services Group held its Sagimet Biosciences (SGMT) position steady in Q1 2026 at 1,500 shares worth $7.84K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Newbridge Financial Services Group first reported a position in SGMT in Q4 2023 and has held it in 9 quarters since. The position peaked at $11.4K in Q2 2025. 88 funds tracked by Wall St. Rank hold SGMT as of Q1 2026.

  • Newbridge Financial Services Group held 1,500 shares of Sagimet Biosciences worth $7.84K as of Q1 2026.
  • Newbridge Financial Services Group left its Sagimet Biosciences share count unchanged in Q1 2026.
  • Sagimet Biosciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #835 holding.
  • Newbridge Financial Services Group first reported a position in Sagimet Biosciences in Q4 2023 and has held it in 9 quarters since.
  • Newbridge Financial Services Group's Sagimet Biosciences position peaked at $11.4K in Q2 2025.
  • 88 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.